Migraine Disorder
12
3
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.4% vs benchmark
8%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (12)
Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD
Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study
Long-term Atogepant in Real-world Practice
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept Study
Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
Aerobic Exercise and Its Impact on Sensory, Musculoskeletal, and Psychosocial Aspects in Migraine
Sleep Hygiene Education to Improve Sleep in Chronic Migraine and Back Pain
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Effectiveness of Tai Chi and Acupuncture on Migraine Attack Prevention and Brain White Matter Changes: A Non-Inferiority RCT
Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine
The Efficacy of Tai Chi Training for the Prophylaxis of Migraine in Chinese Women
An Open Label Trial of ALD403 (Eptinezumab) in Chronic Migraine